Leah M Henry
Overview
Explore the profile of Leah M Henry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berger C, Frahm N, Price D, Mothe B, Ghebremichael M, Hartman K, et al.
J Virol
. 2011 Jul;
85(18):9334-45.
PMID: 21752903
Virus-specific cytotoxic T lymphocytes (CTL) with high levels of functional avidity have been associated with viral clearance in hepatitis C virus infection and with enhanced antiviral protective immunity in animal...
2.
Berger C, Carlson J, Brumme C, Hartman K, Brumme Z, Henry L, et al.
J Exp Med
. 2010 Jan;
207(1):61-75.
PMID: 20065065
CD8+ cytotoxic T lymphocyte (CTL)-mediated immune responses to HIV contribute to viral control in vivo. Epitopes encoded by alternative reading frame (ARF) peptides may be targeted by CTLs as well,...
3.
Bihl F, Berger C, Chisholm 3rd J, Henry L, Bertisch B, Trojan A, et al.
AIDS
. 2009 Jul;
23(14):1918-22.
PMID: 19609199
Kaposi's sarcoma-associated herpesvirus (KSHV) specific T cell responses and KSHV viremia were analyzed in seven HIV-infected patients with active Kaposi's sarcoma lesions who initiated highly active antiretroviral therapy, and were...
4.
Frahm N, Yusim K, Suscovich T, Adams S, Sidney J, Hraber P, et al.
Eur J Immunol
. 2007 Aug;
37(9):2419-33.
PMID: 17705138
Promiscuous binding of T helper epitopes to MHC class II molecules has been well established, but few examples of promiscuous class I-restricted epitopes exist. To address the extent of promiscuity...
5.
Bihl F, Narayan M, Chisholm 3rd J, Henry L, Suscovich T, Brown E, et al.
J Virol
. 2007 Mar;
81(9):4904-8.
PMID: 17329344
The cellular immunity against Kaposi's sarcoma-associated herpesvirus (KSHV) is poorly characterized and has not been compared to T-cell responses against other human herpesviruses. Here, novel and dominant targets of KSHV-specific...
6.
Woodberry T, Suscovich T, Henry L, Davis J, Frahm N, Walker B, et al.
J Infect Dis
. 2005 Oct;
192(9):1513-24.
PMID: 16206065
The evolution of Epstein-Barr virus (EBV)-specific T cell responses that occurs during the acute and persistent stages of infection remains poorly characterized despite its importance for developing immune interventions for...
7.
Woodberry T, Suscovich T, Henry L, August M, Waring M, Kaur A, et al.
J Immunol
. 2005 Sep;
175(7):4355-62.
PMID: 16177076
The characterization of antiviral CTL responses has largely been limited to assessing Ag-specific immune responses in the peripheral blood. Consequently, there is an incomplete understanding of the cellular immune responses...
8.
Woodberry T, Suscovich T, Henry L, Martin J, Dollard S, OConnor P, et al.
J Infect Dis
. 2005 Jul;
192(4):622-9.
PMID: 16028131
Cellular immune responses to Kaposi sarcoma-associated herpesvirus (KSHV), the etiological agent of KS and several other malignancies, are incompletely characterized. We assessed KSHV-specific interferon- gamma enzyme-linked immunospot responses in a...
9.
Bihl F, Loggi E, Chisholm 3rd J, Hewitt H, Henry L, Linde C, et al.
J Transl Med
. 2005 May;
3(1):20.
PMID: 15888204
The assessment of cellular anti-viral immunity is often hampered by the limited availability of adequate samples, especially when attempting simultaneous, high-resolution determination of T cell responses against multiple viral infections....